---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-024878"
form_type: "8-K"
ticker: "VKTX"
cik: "0001607678"
company_name: "Viking Therapeutics, Inc."
filed_at: "2024-03-04T23:59:59+00:00"
generated_at: "2026-06-05T04:44:17.166530+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Viking Therapeutics closes $632.5M public offering of 7.44M shares at $85.00

## Summary
- Closed public offering of 7,441,650 shares at $85.00 each, including full exercise of underwriters' option for 970,650 additional shares.
- Gross proceeds of approximately $632.5 million before underwriting discounts and offering expenses.
- Net proceeds will fund continued development of VK2809, VK2735, VK0214 programs and general corporate purposes.
- Joint book-running managers: Morgan Stanley, Leerink Partners, William Blair, Raymond James, Stifel, Truist Securities.

## SEC filing metadata
- accession: 0000950170-24-024878
- form_type: 8-K
- ticker: VKTX
- cik: 0001607678
- company_name: Viking Therapeutics, Inc.
- filed_at: 2024-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607678/000095017024024878/0000950170-24-024878-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607678/000095017024024878/vktx-20240304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-024878
- JSON: https://secwatch.observer/filing/0000950170-24-024878.json
- Plain text: https://secwatch.observer/filing/0000950170-24-024878.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.